Directori de persones
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Grau: Doctor/a

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publicacions

  • Rayego-Mateos S; Morgado-Pascual JL; Valdivielso JM; Sanz AB; Bosch-Panadero E; Rodrigues-Díez RR; Egido J; Ortiz A; González-Parra E; Ruiz-Ortega M

    TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.

    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 31 2026-2042. .

    [doi:10.1681/ASN.2019111206]

  • Cambray S; Ibarz M; Bermudez-Lopez M; Marti-Antonio M; Bozic M; Fernandez E; Valdivielso JM

    Magnesium Levels Modify the Effect of Lipid Parameters on Carotid Intima Media Thickness.

    Nutrients 12 1-12. .

    [doi:10.3390/nu12092631]

  • Valdivielso, JM; Eritja À; Caus, M; Bozic, M

    Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney.

    Biomolecules 10 1-18. .

    [doi:10.3390/biom10071051]

  • Rayego-Mateos, S; Valdivielso, JM

    New therapeutic targets in chronic kidney disease progression and renal fibrosis.

    Expert Opinion On Therapeutic Targets 24 655-670. .

    [doi:10.1080/14728222.2020.1762173]

  • Dolade, N; Rayego-Mateos, S; Garcia-Carrasco, A; Perez-Gomez, A; Crespo-Masip, M; Guerin, M; Tharaux, PL; Valdivielso, JM

    EPIGENETIC REGULATION OF CHRONIC KIDNEY DISEASE ACCELERATED-ATHEROSCLEROSIS

    NEPHROLOGY DIALYSIS TRANSPLANTATION 35 1041-1041. .

  • Castro-Alonso, C; D'Marco, L; Pomes, J; Del Amo Conill M; Garcia-Diez, AI; Molina, P; Puchades, MJ; Valdivielso, JM; Escudero, V; Bover, J; Navarro-Gonzalez, J; Ribas, B; Pallardo, LM; Gorriz, JL

    Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3?5 Not on Dialysis.

    Journal of Clinical Medicine 9 1-11. .

    [doi:10.3390/jcm9051604]

  • Martinez-Lopez, D; Roldan-Montero, R; Garcia-Marques, F; Nuñez E; Jorge, I; Camafeita, E; Minguez, P; Rodriguez de Cordoba S; Lopez-Melgar, B; Lara-Pezzi, E; Fernandez-Ortiz, A; Ibáñez B; Valdivielso, JM; Fuster, V; Michel, JB; Blanco-Colio, LM; Vazquez, J; Martin-Ventura, JL

    Complement C5 Protein as a Marker of Subclinical Atherosclerosis.

    Journal Of The American College Of Cardiology 75 1926-1941. .

    [doi:10.1016/j.jacc.2020.02.058]

  • Bozic, M; Caus, M; Rodrigues-Diez, RR; Pedraza, N; Ruiz-Ortega, M; Gari, E; Gallel, P; Panades, MJ; Martinez, A; Fernandez, E; Valdivielso, JM

    Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis.

    Nature Communications 11 1943-1943. .

    [doi:10.1038/s41467-020-15732-9]

  • Martinez-Sena, T; Soluyanova, P; Guzman, C; Valdivielso, JM; Castell, JV; Jover, R

    The Vitamin D Receptor Regulates Glycerolipid and Phospholipid Metabolism in Human Hepatocytes.

    Biomolecules 10 -. .

    [doi:10.3390/biom10030493]

  • Solache-Berrocal, G; Barral-Varela, AM; Areces-Rodriguez, S; Junco-Vicente, A; Vallina-Alvarez, A; Corte-Torres, MD; Valdivielso, JM; Llosa, JC; Moris, C; Martin, M; Rodriguez, I

    Correlation of Micro-Computed Tomography Assessment of Valvular Mineralisation with Histopathological and Immunohistochemical Features of Calcific Aortic Valve Disease

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9010029]

  • Palau, V; Riera, M; Duran, X; Valdivielso, JM; Betriu, A; Fernandez, E; Pascual, J; Soler, MJ

    Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 35 130-138. .

    [doi:10.1093/ndt/gfy240]

  • Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

    Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project

    Diabetes & metabolism 45 595-598. .

    [doi:10.1016/j.diabet.2018.04.002]

Projectes

  • Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes
  • Papel de la señalizacion renal por IGF en los eventos tempranos de la enfermedad renal crónica
  • Crosstalk between vascular vitamin D signaling and bone homeostasis in CKD. Implications in mineral metabolism.
  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell